ADAR1 Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.8M | Sell |
345,878
-177,889
| -34% | -$2.98M | 0.89% | 29 |
|
|
2025
Q1 | $8.05M | Buy |
523,767
+377,096
| +257% | +$5.8M | 1.49% | 14 |
|
|
2024
Q4 | $3.23M | Buy |
146,671
+38,500
| +36% | +$849K | 0.65% | 34 |
|
|
2024
Q3 | $1.95M | Buy |
108,171
+5,050
| +5% | +$91K | 0.32% | 49 |
|
|
2024
Q2 | $1.68M | Buy |
103,121
+1,495
| +1% | +$24.3K | 0.32% | 43 |
|
|
2024
Q1 | $1.43M | Sell |
101,626
-9,700
| -9% | -$137K | 0.33% | 48 |
|
|
2023
Q4 | $1.16M | Buy |
+111,326
| New | +$1.16M | 0.42% | 37 |
|